Norbert Suttorp
- Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissueBy Kolja V. Szymanski, Mario Toennies, Anne Becher, Diana Fatykhova, Philippe D. N'Guessan, Birgitt Gutbier, Frederick Klauschen, Frank Neuschaefer-Rube, Paul Schneider, Jens Rueckert, Jens Neudecker, Torsten T. Bauer, Klaus Dalhoff, Daniel Drömann, Achim D. Gruber, Olivia Kershaw, Bettina Temmesfeld-Wollbrueck, Norbert Suttorp, Stefan Hippenstiel and Andreas C. HockeKolja V. Szymanski*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinMario Toennies#Lungenklinik Heckeshorn, HELIOS Klinikum Emil von BehringAnne Becher*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinDiana Fatykhova*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinPhilippe D. N'Guessan*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinBirgitt Gutbier*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinFrederick Klauschen¶Institute of Pathology, Charité – Universitätsmedizin BerlinFrank Neuschaefer-Rube+Institute of Nutrition Science, University of Potsdam, NuthetalPaul Schneider§Dept for General and Thoracic Surgery, DRK ClinicsJens RueckertfDept of General, Visceral, Vascular and Thoracic Surgery, Charité – Universitätsmedizin BerlinJens NeudeckerfDept of General, Visceral, Vascular and Thoracic Surgery, Charité – Universitätsmedizin BerlinTorsten T. Bauer#Lungenklinik Heckeshorn, HELIOS Klinikum Emil von BehringKlaus Dalhoff**Medical Clinic III, University Hospital Schleswig-Holstein, Lübeck, GermanyDaniel Drömann**Medical Clinic III, University Hospital Schleswig-Holstein, Lübeck, GermanyAchim D. Gruber##Dept of Veterinary Pathology, Freie Universität Berlin, BerlinOlivia Kershaw##Dept of Veterinary Pathology, Freie Universität Berlin, BerlinBettina Temmesfeld-Wollbrueck*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinNorbert Suttorp*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinStefan Hippenstiel*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin BerlinAndreas C. Hocke*Dept of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin Berlin
- TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumoniaBy Janine Zahlten, Robert Steinicke, Wilhelm Bertrams, Andreas C. Hocke, Stefanie Scharf, Bernd Schmeck, Martin Witzenrath, Sven Hammerschmidt, Norbert Suttorp and Stefan HippenstielJanine Zahlten*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, BerlinRobert Steinicke*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, BerlinWilhelm Bertrams#Dept of Molecular Pulmonology, German Center for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps University Marburg, MarburgAndreas C. Hocke*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, BerlinStefanie Scharf*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, BerlinBernd Schmeck#Dept of Molecular Pulmonology, German Center for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps University Marburg, MarburgMartin Witzenrath*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, BerlinSven Hammerschmidt¶Dept of Genetics of Microorganisms, Interfaculty Institute of Genetics and Functional Genomics, Ernst-Moritz-Arndt-University, Greifswald, GermanyNorbert Suttorp*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, BerlinStefan Hippenstiel*Dept of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin
- Role of angiopoietins Ang-1 and Ang-2 for the development of acute lung injury in pneumococcal pneumoniaBy Birgitt Gutbier, Katrin Reppe, Anne-Kathrin Neuhauss, Ansgar Santel, Jörg Kaufmann, Norbert Weissmann, Lars Morawitz, Timothy J. Mitchell, Norbert Suttorp and Martin WitzenrathBirgitt Gutbier1Charité-Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyKatrin Reppe1Charité-Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyAnne-Kathrin Neuhauss1Charité-Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyAnsgar Santel2Silence Therapeutics, AG Berlin, Berlin, GermanyJörg Kaufmann2Silence Therapeutics, AG Berlin, Berlin, GermanyNorbert Weissmann3ECCPS, University of Giessen and Marburg Lung Center (UGMLC), Giessen, GermanyLars Morawitz4Charité-Universitätsmedizin Berlin, Institute of Pathology, Berlin, GermanyTimothy J. Mitchell5Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United KingdomNorbert Suttorp1Charité-Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyMartin Witzenrath1Charité-Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, Germany
- Intermedin stabilized endothelial barrier function and attenuated ventilator-induced lung injury in miceBy Holger Christian Müller, Wolfgang Kummer, Uwe Pfeil, Katharina Hellwig, Daniel Will, Andreas Christian Hocke, Stefan Hippenstiel, Norbert Suttorp and Witzenrath MartinHolger Christian Müller1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyWolfgang Kummer2Anatomy and Cell Biology - University of Giessen Lung Center, Justus Liebig Universität Giessen, Giessen, GermanyUwe Pfeil2Anatomy and Cell Biology - University of Giessen Lung Center, Justus Liebig Universität Giessen, Giessen, GermanyKatharina Hellwig1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyDaniel Will1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyAndreas Christian Hocke1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyStefan Hippenstiel1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyNorbert Suttorp1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyWitzenrath Martin1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in community-acquired pneumonia – Results from the German competence network CAPNETZBy Stefan Krüger, Jan Kunde, Oliver Hartmann, Norbert Suttorp, Gernot Rohde and Tobias WelteStefan Krüger1Medical Clinic I, University Clinic RWTH, Aachen, GermanyJan Kunde2Research Department, BRAHMS AG, Henningsdorf, GermanyOliver Hartmann2Research Department, BRAHMS AG, Henningsdorf, GermanyNorbert Suttorp3Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charite- University Medicine, Berlin, GermanyGernot Rohde4Department of Pneumology, Maastricht Medical Centrum, University Hospital, Maastricht, NetherlandsTobias Welte5Department of Pneumology, Hannover Medical School, University Clinic, Hannover, Germany
- Sphingosine kinase-1 and sphingosine-1-phosphate promote the development of acute lung injury in pneumoccocal pneumoniaBy Birgitt Gutbier, Stefanie M. Schönrock, Rainer Haberberger, Andreas C. Hocke, Stefan Hippenstiel, Anja Lüth, Burkhard Kleuser, Wilhelm G. Bertrams, Kolja Szymanski, Katrin Reppe, Holger C. Müller-Redetzky, Bernd Schmeck, Manfred Andratsch, Timothy J. Mitchell, Hartwig Schütte, Konstantin Mayer, Norbert Suttorp, Martin Witzenrath and Capnetz Study GroupBirgitt Gutbier1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyStefanie M. Schönrock1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyRainer Haberberger2Institute of Anatomy and Histology, Flinders University, Adelaide, AustraliaAndreas C. Hocke1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyStefan Hippenstiel1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyAnja Lüth3German Institute of Human Nutrition, University of Potsdam, GermanyBurkhard Kleuser3German Institute of Human Nutrition, University of Potsdam, GermanyWilhelm G. Bertrams4Molecular Pneumology, Philipps University, Marburg, GermanyKolja Szymanski1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyKatrin Reppe1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyHolger C. Müller-Redetzky1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyBernd Schmeck4Molecular Pneumology, Philipps University, Marburg, GermanyManfred Andratsch5Dept. of Physiology, University of Innsbruck, AustriaTimothy J. Mitchell6Glasgow Biomedical Research Centre, University of Glasgow, United KingdomHartwig Schütte1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyKonstantin Mayer7Medical Clinic II, University of Giessen and Marburg Lung Center, Gießen, GermanyNorbert Suttorp1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, GermanyMartin Witzenrath1Dept. of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin, Berlin, Germany8Capnetz, Stiftung, Hannover, Germany
- Angiopoietins: Possible biomarkers in severe pneumonia?By Anne-Kathrin Neuhauß, Birgitt Gutbier, Taut Friedemann, Andreas Günther, Doris Stoll, Norbert Weißmann, Timothy J. Mitchell, Hartwig Schütte, Norbert Suttorp, Martin Witzenrath and Capnetz Study GroupAnne-Kathrin Neuhauß1Department for Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin, Berlin, GermanyBirgitt Gutbier1Department for Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin, Berlin, GermanyTaut Friedemann2Nycomed, GmbH, Konstanz, GermanyAndreas Günther3Medical Clinic II, University of Giessen and Marburg Lung Center (UGMLC), Gießen,, GermanyDoris Stoll1Department for Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin, Berlin, GermanyNorbert Weißmann3Medical Clinic II, University of Giessen and Marburg Lung Center (UGMLC), Gießen,, GermanyTimothy J. Mitchell4Glasgow Biomedical Research Centre, University of Glasgow, United KingdomHartwig Schütte1Department for Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin, Berlin, GermanyNorbert Suttorp1Department for Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin, Berlin, GermanyMartin Witzenrath1Department for Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin, Berlin, Germany5Capnetz, Stiftung, Hannover, Germany
- Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumoniaBy Katrin Reppe, Peter Radünzel, Thomas Tschernig, Thorsten Wolff, Achim Gruber, Norbert Suttorp and Martin WitzenrathKatrin Reppe1Department of Infectious and Respiratory Diseases, Charité Berlin, Berlin, GermanyPeter Radünzel1Department of Infectious and Respiratory Diseases, Charité Berlin, Berlin, GermanyThomas Tschernig2Institute of Anatomy and Cell Biology, Medical Faculty of the Saarland University, Homburg/Saar, GermanyThorsten Wolff3Department of Infectious Diseases, Robert Koch Institute, Berlin, GermanyAchim Gruber4Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, GermanyNorbert Suttorp1Department of Infectious and Respiratory Diseases, Charité Berlin, Berlin, GermanyMartin Witzenrath1Department of Infectious and Respiratory Diseases, Charité Berlin, Berlin, Germany
- Admission serum glucose levels are a risk factor predicting short- and long-term mortality in community acquired pneumoniaBy Philipp M. Lepper, Sebastian R. Ott, Eveline Nüesch, Maximilian von Eynatten, Christian Schumann, Mathias W. Pletz, Nicole Mealing, Tobias Welte, Torsten T. Bauer, Norbert Suttorp, Peter Jüni, Robert Bals and Gernot RohdePhilipp M. Lepper1Dept. of Internal Medicine V, University Hospital of Saarland, Homburg, GermanySebastian R. Ott2Dept. of Pneumology, Inselspital, SwitzerlandEveline Nüesch3Institute for Social and Preventive Medicine, University of Bern, SwitzerlandMaximilian von Eynatten4Dept. of Nephrology, Technical University, Munich, GermanyChristian Schumann5Dept. of Internal Medicine II, University Hospital, Ulm, GermanyMathias W. Pletz6Division of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Jena, GermanyNicole Mealing3Institute for Social and Preventive Medicine, University of Bern, SwitzerlandTobias Welte7Dept. of Pneumology, Hannover Medical School, University of Hannover, GermanyTorsten T. Bauer8Dept. of Pneumology, Lungenklinik Heckeshorn, Klinikum Emil von Behring, Berlin, GermanyNorbert Suttorp9Dept. of Pneumology and Infectious Diseases, Charite, Berlin, GermanyPeter Jüni3Institute for Social and Preventive Medicine, University of Bern, SwitzerlandRobert Bals1Dept. of Internal Medicine V, University Hospital of Saarland, Homburg, GermanyGernot Rohde10Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, Netherlands
- Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullinBy Holger Müller-Redetzky, Daniel Will, Katharina Hellwig, Kummer Wolfgang, Thomas Tschernig, Uwe Pfeil, Renate Paddenberg, Stefan Hippenstiel and Norbert SuttorpHolger Müller-Redetzky1Department for Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyDaniel Will1Department for Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyKatharina Hellwig1Department for Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyKummer Wolfgang2Institute for Anatomy and Cell Biology, Universities of Giessen and Marburg Lung Center, Justus-Liebig-University, Giessen, GermanyThomas Tschernig3Anatomy and Cell Biology, Saarland University Faculty of Medicine, Homburg, GermanyUwe Pfeil2Institute for Anatomy and Cell Biology, Universities of Giessen and Marburg Lung Center, Justus-Liebig-University, Giessen, GermanyRenate Paddenberg2Institute for Anatomy and Cell Biology, Universities of Giessen and Marburg Lung Center, Justus-Liebig-University, Giessen, GermanyStefan Hippenstiel1Department for Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyNorbert Suttorp1Department for Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Streptococcus pneumoniae induced regulation of cyclooxygenase-2 in human lung tissueBy Kolja V. Szymanski, Mario Toennies, Anne Becher, Diana Fatykhova, Philippe D. N'Guessan, Birgitt Gutbier, Frederick Klauschen, Frank Neuschaefer-Rube, Paul Schneider, Jens Rueckert, Jens Neudecker, Torsten T. Bauer, Klaus Dalhoff, Daniel Drömann, Achim D. Gruber, Olivia Kershaw, Bettina Temmesfeld-Wollbrueck, Norbert Suttorp, Stefan Hippenstiel and Andreas C. HockeArticle | Published in 2012 in European Respiratory JournalKolja V. SzymanskiMario ToenniesAnne BecherDiana FatykhovaPhilippe D. N'GuessanBirgitt GutbierFrederick KlauschenFrank Neuschaefer-RubePaul SchneiderJens RueckertJens NeudeckerTorsten T. BauerKlaus DalhoffDaniel DrömannAchim D. GruberOlivia KershawBettina Temmesfeld-WollbrueckNorbert SuttorpStefan HippenstielAndreas C. Hocke
- TLR9- and Src-dependent expression of KLF4 controls IL-10 expression in pneumoniaBy Janine Zahlten, Robert Steinicke, Wilhelm Bertrams, Andreas C. Hocke, Stefanie Scharf, Bernd Schmeck, Martin Witzenrath, Sven Hammerschmidt, Norbert Suttorp and Stefan HippenstielArticle | Published in 2012 in European Respiratory JournalJanine ZahltenRobert SteinickeWilhelm BertramsAndreas C. HockeStefanie ScharfBernd SchmeckMartin WitzenrathSven HammerschmidtNorbert SuttorpStefan Hippenstiel
- Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsisBy Müller-Redetzky Holger, Kellermann Ute, Thomas Tschernig, Sandra Wienhold, Marfa Polikarpova, Katharina Hellwig, Axel Vater, Christian Maasch, Sven Klussmann, Michael Menger, Norbert Suttorp and Martin WitzenrathMüller-Redetzky Holger1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyKellermann Ute1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyThomas Tschernig2Institute of Anatomy and Cell Biology, Saarland University, Faculty of Medicine, Homburg, GermanySandra Wienhold1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyMarfa Polikarpova1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyKatharina Hellwig1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyAxel Vater3NOXXON Pharma, NOXXON Pharma, Berlin, GermanyChristian Maasch3NOXXON Pharma, NOXXON Pharma, Berlin, GermanySven Klussmann3NOXXON Pharma, NOXXON Pharma, Berlin, GermanyMichael Menger4Institute for Clinical and Experimental Surgery, Saarland University, Faculty of Medicine, Homburg, GermanyNorbert Suttorp1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyMartin Witzenrath1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Strict bed rest after EBV implant reduces pneumothorax rateBy Dominik Herzog, Stefan Hippenstiel, Dirk Schürmann, Felix Döllinger, Alexander Pöllinger, Bettina Temmesfeld-Wollbrück, Norbert Suttorp and Ralf-Harto HübnerDominik Herzog1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyStefan Hippenstiel1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyDirk Schürmann1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyFelix Döllinger2Institute of Radiology, Charité -Universitätsmedizin Berlin, Charité -Universitätsmedizin Berlin, Berlin, GermanyAlexander Pöllinger2Institute of Radiology, Charité -Universitätsmedizin Berlin, Charité -Universitätsmedizin Berlin, Berlin, GermanyBettina Temmesfeld-Wollbrück1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyNorbert Suttorp1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyRalf-Harto Hübner1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany
- Prevalence of interlobar collateral ventilation in COPD patientsBy Dominik Herzog, Stefan Hippenstiel, Dirk Schürmann, Felix Döllinger, Alexander Pöllinger, Bettina Temmesfeld-Wollbrück, Norbert Suttorp and Ralf-Harto HübnerDominik Herzog1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyStefan Hippenstiel1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyDirk Schürmann1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyFelix Döllinger2Institute of Radiology, Charité -Universitätsmedizin Berlin, Charité -Universitätsmedizin Berlin, Berlin, GermanyAlexander Pöllinger2Institute of Radiology, Charité -Universitätsmedizin Berlin, Charité -Universitätsmedizin Berlin, Berlin, GermanyBettina Temmesfeld-Wollbrück1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyNorbert Suttorp1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, GermanyRalf-Harto Hübner1Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany
- The synthetic streptococcus pneumoniae oligosaccharide conjugate protected mice from severe pneumoniaBy Katrin Reppe, Chakkumkal Anish, Roland Bell, Sharavathi G. Parameswarappa, Subramanian Govindan, Claney L. Pereira, Kristina Dietert, Leif E. Sander, Achim D. Gruber, Norbert Suttorp, Peter H. Seeberger and Martin WitzenrathKatrin Reppe1Charité - Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyChakkumkal Anish2Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Potsdam, GermanyRoland Bell1Charité - Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanySharavathi G. Parameswarappa2Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Potsdam, GermanySubramanian Govindan2Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Potsdam, GermanyClaney L. Pereira2Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Potsdam, GermanyKristina Dietert4Freie Universität Berlin, Institute of Veterinary Pathology, Berlin, GermanyLeif E. Sander1Charité - Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyAchim D. Gruber4Freie Universität Berlin, Institute of Veterinary Pathology, Berlin, GermanyNorbert Suttorp1Charité - Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, GermanyPeter H. Seeberger2Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Potsdam, Germany3Freie Universität Berlin, Institute of Chemistry and Biochemistry, Berlin, GermanyMartin Witzenrath1Charité - Universitätsmedizin Berlin, Department of Infectious and Respiratory Diseases, Berlin, Germany
- PKCα deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 via increased TXA2 receptor expressionBy Christoph Tabeling, Elena Noe, Jan Naujoks, Jan-Moritz Doehn, Stefan Hippenstiel, Bastian Opitz, Norbert Suttorp, Robert Klopfleisch and Martin WitzenrathChristoph Tabeling1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyElena Noe1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyJan Naujoks1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyJan-Moritz Doehn1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyStefan Hippenstiel1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyBastian Opitz1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyNorbert Suttorp1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, GermanyRobert Klopfleisch2Department of Veterinary Medicine, Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, GermanyMartin Witzenrath1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin, Berlin, Germany
- Increasing the inspiratory time and I:E ratio during mechanical ventilation aggravates ventilator-induced lung injury in miceBy Holger Müller-Redetzky, Matthias Felten, Marfa Polikarpova, Katharina Hellwig, Sandra Wienhold, Jan Naujoks, Bastian Opitz, Olivia Kershaw, Achim Gruber, Norbert Suttorp and Martin WitzenrathHolger Müller-Redetzky1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyMatthias Felten1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyMarfa Polikarpova1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyKatharina Hellwig1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanySandra Wienhold1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyJan Naujoks1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyBastian Opitz1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyOlivia Kershaw2Department of Veterinary Pathology, Freie Universität Berlin, Berlin, GermanyAchim Gruber2Department of Veterinary Pathology, Freie Universität Berlin, Berlin, GermanyNorbert Suttorp1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyMartin Witzenrath1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
- Therapeutic strategies in pneumonia: going beyond antibioticsBy Holger Müller-Redetzky, Jasmin Lienau, Norbert Suttorp and Martin WitzenrathHolger Müller-RedetzkyDept of Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin Berlin, Berlin, GermanyJasmin LienauDept of Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin Berlin, Berlin, GermanyNorbert SuttorpDept of Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin Berlin, Berlin, GermanyMartin WitzenrathDept of Infectious Diseases and Pulmonary Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
- Cystic fibrosis transmembrane conductance regulator and sphingolipids regulate hypoxic pulmonary vasoconstrictionBy Christoph Tabeling, Hanpo Yu, Liming Wang, Hannes Ranke, Neil M. Goldenberg, Diana Zabini, Elena Noe, Adrienn Krauszman, Birgitt Gutbier, Jun Yin, Michael Schaefer, Christoph Arenz, Andreas C. Hocke, Norbert Suttorp, Richard L. Proia, Martin Witzenrath and Wolfgang M. KueblerChristoph Tabeling1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyHanpo Yu2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyLiming Wang2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyHannes Ranke2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyNeil M. Goldenberg2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyDiana Zabini2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyElena Noe1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyAdrienn Krauszman2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyBirgitt Gutbier1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyJun Yin2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyMichael Schaefer4Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, GermanyChristoph Arenz5Institute for Chemistry, Humboldt University, Berlin, GermanyAndreas C. Hocke1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyNorbert Suttorp1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyRichard L. Proia6Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United StatesMartin Witzenrath1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyWolfgang M. Kuebler2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.